NasdaqGS - Delayed Quote • USD
ICU Medical, Inc. (ICUI)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:20 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 0.82 | 1 | 4.73 | 6.78 |
Low Estimate | 0.76 | 0.93 | 4.64 | 6.5 |
High Estimate | 0.89 | 1.04 | 4.78 | 7.31 |
Year Ago EPS | 1.74 | 1.88 | 6.86 | 4.73 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 552.25M | 557.4M | 2.28B | 2.37B |
Low Estimate | 546.9M | 556.1M | 2.27B | 2.32B |
High Estimate | 555.8M | 558.8M | 2.29B | 2.39B |
Year Ago Sales | 568.65M | -- | 2.21B | 2.28B |
Sales Growth (year/est) | -2.90% | -- | 2.90% | 3.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 1.43 | 1.6 | 1.38 | 1.19 |
EPS Actual | 1.74 | 1.88 | 1.57 | 1.57 |
Difference | 0.31 | 0.28 | 0.19 | 0.38 |
Surprise % | 21.70% | 17.50% | 13.80% | 31.90% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.82 | 1 | 4.73 | 6.78 |
7 Days Ago | 0.82 | 1 | 4.73 | 6.78 |
30 Days Ago | 0.82 | 1 | 4.73 | 6.78 |
60 Days Ago | 0.89 | 0.9 | 5.18 | 7.31 |
90 Days Ago | 0.89 | 0.9 | 5.28 | 7.27 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ICUI | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -52.90% | -- | -- | 1.60% |
Next Qtr. | -46.80% | -- | -- | 10.50% |
Current Year | -31.00% | -- | -- | 5.20% |
Next Year | 43.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 16.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | -4.67% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Keybanc: Overweight to Overweight | 2/28/2024 |
Initiated | Keybanc: Overweight | 2/6/2024 |
Initiated | CL King: Buy | 12/14/2023 |
Maintains | Keybanc: Overweight | 5/9/2023 |
Downgrade | Raymond James: Outperform to Market Perform | 11/8/2022 |
Maintains | Raymond James: Outperform | 8/9/2022 |
Related Tickers
MMSI Merit Medical Systems, Inc.
72.03
+1.46%
ATRI Atrion Corporation
402.35
+4.32%
UTMD Utah Medical Products, Inc.
68.58
+2.01%
RGEN Repligen Corporation
157.14
+0.05%
AZTA Azenta, Inc.
50.65
+0.32%
NVST Envista Holdings Corporation
19.96
+1.06%
COO The Cooper Companies, Inc.
90.42
+0.01%
TFX Teleflex Incorporated
206.56
-0.40%
KRMD KORU Medical Systems, Inc.
2.0800
+0.97%
OSUR OraSure Technologies, Inc.
5.28
+0.57%